Opinion: Medicare could jumpstart our failing biosimilars markets

Everyone understands the importance of generic drugs.  When an innovative branded medication loses its patents, the therapy becomes widely available very inexpensively because generic copies of the product come onto the market.  Health insurance companies promote the generic versions through their formularies.  Consumers benefit, and pharmaceutical companies have incentive to find the next innovative branded medication.